AI chip startup Cerebras files for IPO
AI chip startup Cerebras has filed for an IPO, signaling significant investor interest in the specialized hardware powering artificial intelligence.
Read on TechCrunch →
Breakout Ventures has secured $114 million to invest in early-stage startups focused on scientific innovation, with a particular emphasis on AI applications in fields like biology and chemistry.
Why it matters
This funding round signifies continued investor confidence in the intersection of AI and scientific discovery. By backing startups that apply AI to complex fields like biology and chemistry, Breakout Ventures aims to accelerate innovation and potentially lead to significant advancements in areas such as drug discovery, materials science, and personalized medicine. This investment highlights the growing recognition of AI as a transformative tool for solving some of humanity's most pressing scientific challenges.
A venture capital firm called Breakout Ventures just raised $114 million. They plan to use this money to invest in new companies that are using AI to make discoveries in science, like in medicine and chemistry.
AI chip startup Cerebras has filed for an IPO, signaling significant investor interest in the specialized hardware powering artificial intelligence.
Read on TechCrunch →App store launches are reportedly surging in 2026, with AI tools potentially driving this growth.
Read on TechCrunch →New iPhone app Gigs uses AI to transform users' concert history from digital memorabilia into a personalized live music archive.
Read on TechCrunch →